71. Idiopathic osteonecrosis of the femoral head
3 clinical trials, 5 drugs (DrugBank: 4 drugs), 4 drug target genes, 10 drug target pathways
Searched query = "Idiopathic osteonecrosis of the femoral head", "Idiopathic femoral head necrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03112785 (ClinicalTrials.gov) | March 17, 2011 | 7/3/2017 | Fitmore Versus CLS Stem in Total Hip Arthroplasty. Bilateral One-stage Operations | Randomized Comparison Between the Fitmore and the CLS Stem in Patients Operated in One-stage Due to Bilateral Symptomatous Hip Disease | Primary Hip Osteoarthritis;Secondary Hip Osteoarthritis Due to Idiopathic Femoral Head Necrosis, Childhood or Inflammatory Disease;Bilateral Hip Disease;Surgical Treatment | Device: Total hip arthroplasty (Fitmore or CLS uncemented femoral stem made by Zimmer-Biomet, Warshaw, USA) | Sahlgrenska University Hospital, Sweden | Zimmer Biomet | Active, not recruiting | 35 Years | 75 Years | All | 44 | N/A | NULL |